Cited by 250Diabetes Management and ResearchDiabetes Treatment and ManagementDiabetes Management and Education

The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.

Diabetes technology-continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an Endocrine Society clinical practice guideline

Open access

Peters, Anne L., Ahmann, Andrew J., Battelino, Tadej, Evert, Alison, Hirsch, Irl B., Murad, M. Hassan, Winter, William E., Wolpert, Howard·2016·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jc.2016-2534

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes. PARTICIPANTS: The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical writer. The American Association for Clinical Chemistry, the American Association of Diabetes Educators, and the European Society of Endocrinology co-sponsored this guideline. EVIDENCE: The Task Force developed this evidence-based guideline using the Grading of Recommendations, Assessment, Development, and Evaluation system to describe the strength of recommendations and the quality of evidence. The Task Force commissioned one systematic review and used the best available evidence from other published systematic reviews and individual studies. CONSENSUS PROCESS: One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of the Endocrine Society, the American Association for Clinical Chemistry, the American Association of Diabetes Educators, and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines. CONCLUSIONS: Continuous subcutaneous insulin infusion and continuous glucose monitoring have an important role in the treatment of diabetes. Data from randomized controlled trials are limited on the use of medical devices, but existing studies support the use of diabetes technology for a wide variety of indications. This guideline presents a review of the literature and practice recommendations for appropriate device use.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1210/jc.2016-2534

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Part of this paper’s reference list could not be split into single entries.

1 retracted

RETRACTED: The impact of anxiety and depression on patients within a large type 1 diabetes insulin pump population. An observational study
Grant, P. S., Dorota Dworakowska, B., DeZoysa, N., & Barnes, D. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.06.003 · Cited by 17
Retracted
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066
Self-citation
The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview
Nathan, D. M., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2112 · Cited by 1,832
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes : dose adjustment for normal eating (DAFNE) randomised controlled trial
Amiel, S. A., Beveridge, S., Bradley, C., Gianfrancesco, C., Heller, S. R., James, P., McKeown, N., Newton, D. F., Newton, L. D., Oliver, L., et al. (2002) · Deakin Research Online (Deakin University) · Cited by 723

Flagged first, then by citations

Show all 115 references

Research works printed but not linked: 2

American Diabetes Association. 7. Approaches to glycemic treat- ment. Diabetes Care. 2015;38:S41-S48.
Golden SH, Brown T, Yeh HC, et al. AHRQ Comparative Effec- tiveness Reviews. Methods for Insulin Delivery and Glucose Mon- itoring: Comparative Effectiveness Review No. 57. Rockville, MD: Agency for Healthcare Research and Quality; 2012.

Sorted by citations

Type 1 diabetes
DiMeglio, L. A., Evans-Molina, C., & Oram, R. A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31320-5 · Cited by 1,561
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496
Self-citation
Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring
Bergenstal, R. M., Beck, R. W., Close, K. L., Grunberger, G., Sacks, D. B., Kowalski, A., Brown, A. S., Heinemann, L., Aleppo, G., Ryan, D. B., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1581 · Cited by 684
Continuous glucose monitoring sensors for diabetes management: A review of technologies and applications
Cappon, G., Vettoretti, M., Sparacino, G., & Facchinetti, A. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0121 · Cited by 477
Continuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes
Rodbard, D. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0035 · Cited by 458
7. Diabetes Technology: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s007 · Cited by 358
7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
REPLACE-BG: a randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type 1 diabetes
Aleppo, G., Ruedy, K. J., Riddlesworth, T. D., Kruger, D. F., Peters, A. L., Hirsch, I., Bergenstal, R. M., Toschi, E., Ahmann, A. J., Shah, V. N., et al. (2017) · Diabetes Care · doi:10.2337/dc16-2482 · Cited by 329
Self-citation
Continuous glucose monitoring: A review of the technology and clinical use
Klonoff, D. C., Ahn, D., & Drincic, A. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.08.005 · Cited by 320
7. Diabetes Technology: Standards of Care in Diabetes — 2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s007 · Cited by 301
American Association of Clinical Endocrinology clinical practice guideline: the use of advanced technology in the management of persons with diabetes mellitus
Grunberger, G., Sherr, J., Allende, M., Blevins, T., Bode, B., Handelsman, Y., Hellman, R., Lajara, R., Roberts, V. L., Rodbard, D., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.008 · Cited by 288
7. Diabetes Technology: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s007 · Cited by 281
Type 1 Diabetes Mellitus
Syed, F. Z. (2022) · Annals of Internal Medicine · doi:10.7326/aitc202203150 · Cited by 289
Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital
Umpierrez, G. E., & Klonoff, D. C. (2018) · Diabetes Care · doi:10.2337/dci18-0002 · Cited by 260
An Effective Model of Diabetes Care and Education: The ADCES7 Self-Care Behaviors™
Kolb, L. E. (2021) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721720978154 · Cited by 287
7. Diabetes Technology: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc20-s007 · Cited by 261
Type 1 diabetes
Quattrin, T., Mastrandrea, L. D., & Walker, L. S. K. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00223-4 · Cited by 292
Glycemic outcomes in adults with T1D are impacted more by continuous glucose monitoring than by insulin delivery method: 3 years of follow-up from the COMISAIR study
Šoupal, J., Petruželková, L., Grunberger, G., Hásková, A., Flekač, M., Matoulek, M., Mikeš, O., Pelcl, T., Škrha, J., Horová, E., et al. (2020) · Diabetes Care · doi:10.2337/dc19-0888 · Cited by 242
Evolution of Insulin Delivery Devices: From Syringes, Pens, and Pumps to DIY Artificial Pancreas
Kesavadev, J., Saboo, B., Krishna, M. B., & Krishnan, G. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00831-z · Cited by 221
7. Diabetes Technology: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s007 · Cited by 202
Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring
Edelman, S. V., Argento, N. B., Pettus, J., & Hirsch, I. B. (2018) · Diabetes Care · doi:10.2337/dc18-1150 · Cited by 209
Self-citation
Use of flash glucose-sensing technology for 12 months as a replacement for blood glucose monitoring in insulin-treated type 2 diabetes
Haak, T., Hanaire, H., Ajjan, R., Hermanns, N., Riveline, J.-P., & Rayman, G. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0255-6 · Cited by 188
An Effective Model of Diabetes Care and Education: Revising the AADE7 Self-Care Behaviors ®
American Association of Diabetes Educators (2020) · The Diabetes Educator · doi:10.1177/0145721719894903 · Cited by 184
7. Diabetes Technology: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s007 · Cited by 179
Clinical Use of Continuous Glucose Monitoring in Adults with Type 2 Diabetes
Carlson, A. L., Mullen, D. M., & Bergenstal, R. M. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0024 · Cited by 181
RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020
Madhu, S., Chawla, R., Makkar, B. M., Ghosh, S. K., Saboo, B., & Kalra, S. (2020) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_225_20 · Cited by 182
7. Diabetes Technology: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s007 · Cited by 215
Self-citation
Technology in the management of type 1 diabetes mellitus — current status and future prospects
Tauschmann, M., & Hovorka, R. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0044-y · Cited by 165
Diagnosis and Treatment of Type 2 Diabetes in Adults
Kalyani, R. R., Neumiller, J. J., Maruthur, N. M., & Wexler, D. J. (2025) · JAMA · doi:10.1001/jama.2025.5956 · Cited by 145
Management of hypoglycemia in older adults with type 2 diabetes
Freeman, J. S. (2019) · Postgraduate Medicine · doi:10.1080/00325481.2019.1578590 · Cited by 153
Improving the clinical value and utility of CGM systems: issues and recommendations
Petrie, J. R., Peters, A. L., Bergenstal, R. M., Holl, R. W., Fleming, G. A., & Heinemann, L. (2017) · Diabetologia · doi:10.1007/s00125-017-4463-4 · Cited by 143
Self-citation
A Clinical Overview of Insulin Pump Therapy for the Management of Diabetes: Past, Present, and Future of Intensive Therapy
Berget, C., Messer, L. H., & Forlenza, G. P. (2019) · Diabetes Spectrum · doi:10.2337/ds18-0091 · Cited by 151
Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations
Petrie, J. R., Peters, A. L., Bergenstal, R. M., Holl, R. W., Fleming, G. A., & Heinemann, L. (2017) · Diabetes Care · doi:10.2337/dci17-0043 · Cited by 135
Self-citation
A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes
Aleppo, G., Laffel, L. M., Ahmann, A., Hirsch, I. B., Kruger, D. F., Peters, A. L., Weinstock, R. S., & Harris, D. R. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00388 · Cited by 129
Self-citation
Continuous Glucose Monitoring: A Brief Review for Primary Care Practitioners
Ajjan, R., Slattery, D., & Wright, E. E. (2019) · Advances in Therapy · doi:10.1007/s12325-019-0870-x · Cited by 133
Role of continuous glucose monitoring for type 2 in diabetes management and research
Vigersky, R. A., & Shrivastav, M. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.10.007 · Cited by 117
How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring?
Ajjan, R. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0021 · Cited by 104
Approach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults
Kudva, Y. C., Ahmann, A., Bergenstal, R. M., Gavin, J. R., Kruger, D. F., Midyett, L. K., Miller, E. M., & Harris, D. R. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00294 · Cited by 99
Self-citation
Evolution of Diabetes Technology
Dovč, K., & Battelino, T. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.10.009 · Cited by 93
Self-citation
Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: a pilot, multicentre, randomised controlled trial
Ajjan, R. A., Jackson, N., & Thomson, S. A. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164119827456 · Cited by 79
Hypoglycemia unawareness and autonomic dysfunction in diabetes: Lessons learned and roles of diabetes technologies
Lin, Y. K., Fisher, S. J., & Pop‐Busui, R. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13290 · Cited by 82
Rates and Correlates of Uptake of Continuous Glucose Monitors Among Adults with Type 2 Diabetes in Primary Care and Endocrinology Settings
Mayberry, L. S., Guy, C., Hendrickson, C. D., McCoy, A. B., & Elasy, T. A. (2023) · Journal of General Internal Medicine · doi:10.1007/s11606-023-08222-3 · Cited by 82
Is insulin pump therapy effective in Type 1 diabetes?
Pickup, J. C. (2018) · Diabetic Medicine · doi:10.1111/dme.13793 · Cited by 79
Continuous Glucose Monitoring in Primary Care: Understanding and Supporting Clinicians’ Use to Enhance Diabetes Care
Oser, T. K., Hall, T. L., Dickinson, L. M., Callen, E. F., Carroll, J. K., Nease, D. E., Michaels, L. C., & Oser, S. M. (2022) · The Annals of Family Medicine · doi:10.1370/afm.2876 · Cited by 81
Monitoring Technologies- Continuous Glucose Monitoring, Mobile Technology, Biomarkers of Glycemic Control
Reddy, N., Verma, N., & Dungan, K. M. (2020) · MDText.com, Inc. eBooks · Cited by 68
Continuous glucose monitoring: a review of the evidence, opportunities for future use and ongoing challenges
Wood, A. J., O'Neal, D. N., Furler, J., & Ekinci, E. I. (2018) · Internal Medicine Journal · doi:10.1111/imj.13770 · Cited by 66
Time in range centered diabetes care
Dovč, K., & Battelino, T. (2021) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.30.1 · Cited by 66
Self-citation
Continuous Glucose Monitoring Integration in Clinical Practice: A Stepped Guide to Data Review and Interpretation
Aleppo, G., & Webb, K. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818813581 · Cited by 67
Diabetes technology in the inpatient setting for management of hyperglycemia
Davis, G. M., Galindo, R. J., Migdal, A. L., & Umpierrez, G. E. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.11.002 · Cited by 62
Racial Disparities in Diabetes Technology Use and Outcomes in Type 1 Diabetes in a Safety-Net Hospital
Fantasia, K. L., Wirunsawanya, K., Lee, C., & Rizo, I. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296821995810 · Cited by 62
Disturbances in Insulin–Glucose Metabolism in Patients With Advanced Renal Disease With and Without Diabetes
Rahhal, M.-N., Gharaibeh, N. E., Rahimi, L., & Ismail‐Beigi, F. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00286 · Cited by 64
Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring System
Deiss, D., Szadkowska, A., Gordon, D., Mallipedhi, A., Schütz-Fuhrmann, I., Aguilera, E., Ringsell, C., Block, C. E. M. D., & Irace, C. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0397 · Cited by 56
Continuous Glucose Monitoring with Multiple Daily Insulin Treatment: Outcome Studies
McGill, J. B., & Ahmann, A. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0090 · Cited by 49
Self-citation
Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
Evans, M., Hicks, D., Patel, D., Patel, V., McEwan, P. C., & Dashora, U. K. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-00728-6 · Cited by 47
Managing Patients with Insulin Pumps and Continuous Glucose Monitors in the Hospital: to Wear or Not to Wear
Yeh, T., Yeung, M., & Curanaj, F. A. M. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01375-7 · Cited by 46
Improved HBa1c, total daily insulin dose, and treatment satisfaction with insulin pump therapy compared to multiple daily insulin injections in patients with type 2 diabetes irrespective of baseline c-peptide levels
Vigersky, R. A., Huang, S., Cordero, T. L., Shin, J., Lee, S. W., Chhabra, H., Kaufman, F. R., & Cohen, O. (2018) · Endocrine Practice · doi:10.4158/ep-2017-0234 · Cited by 43
Trends and Disparities in Technology Use and Glycemic Control in Type 1 Diabetes
Fang, M., Xu, Y., Ballew, S. H., Coresh, J., Echouffo-Tcheugui, J. B., Selvin, E., & Shin, J. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.26353 · Cited by 45
Time in range in pregnancy: is there a role?
Wyckoff, J. A., & Brown, F. M. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0103 · Cited by 39
Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes
Kravarusic, J., & Aleppo, G. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.10.006 · Cited by 46
In-Hospital Diabetes Management by a Diabetes Team and Insulin Titration Algorithms Based on Continuous Glucose Monitoring or Point-of-Care Glucose Testing in Patients With Type 2 Diabetes (DIATEC): A Randomized Controlled Trial
Olsen, M. T., Klarskov, C. K., Jensen, S. H., Rasmussen, L. M., Lindegaard, B., Andersen, J. A., Gottlieb, H., Lunding, S., Pedersen‐Bjergaard, U., Hansen, K. B., et al. (2025) · Diabetes Care · doi:10.2337/dc24-2222 · Cited by 44
RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020
Chawla, R., Madhu, S. V., Makkar, B. M., Ghosh, S. K., Saboo, B., Kalra, S., & On behalf of RSSDI-ESI Consensus Group (2020) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-020-00819-2 · Cited by 44
A retrospective in‐depth analysis of continuous glucose monitoring datasets for patients with hepatic glycogen storage disease: Recommended outcome parameters for glucose management
Peeks, F., Hoogeveen, I. J., Feldbrugge, R. L., Burghard, R., de Boer, F., Fokkert‐Wilts, M. J., van der Klauw, M. M., Oosterveer, M. H., & Derks, T. G. J. (2021) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12383 · Cited by 42
Real-time continuous glucose monitoring in adolescents and young adults with type 2 diabetes can improve quality of life
Chesser, H., Srinivasan, S., Puckett, C., Gitelman, S. E., & Wong, J. C. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221139873 · Cited by 40
Glucose-responsive insulin delivery for type 1 diabetes: The artificial pancreas story
Bally, L., Thabit, H., & Hovorka, R. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.12.022 · Cited by 41
Intermittent Use of Continuous Glucose Monitoring: Expanding the Clinical Value of CGM
Ziegler, R., Heinemann, L., Freckmann, G., Schnell, O., Hinzmann, R., & Kulzer, B. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820905577 · Cited by 40
Use of Continuous Glucose Monitors to Manage Type 1 Diabetes Mellitus: Progress, Challenges, and Recommendations
Friedman, J. G., Cardona, Z., Szmuilowicz, E. D., & Aleppo, G. (2023) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s374663 · Cited by 43
Hybrid Closed-Loop Systems for the Treatment of Type 1 Diabetes: A Collaborative, Expert Group Position Statement for Clinical Use in Central and Eastern Europe
Janež, A., Battelino, T., Klupa, T., Kocsis, G., Kuricova, M., Lalic, N. M., Stoian, A. P., Prázný, M., Rahelić, D., Šoupal, J., et al. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01160-5 · Cited by 44
Self-citation
Glycemic Management in Adults With Type 1 Diabetes
McGibbon, A., Adams, L., Ingersoll, K. S., Kader, T., & Tugwell, B. D. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.012 · Cited by 42
Academy of Nutrition and Dietetics: Revised 2017 standards of practice and standards of professional performance for registered dietitian nutritionists (competent, proficient, and expert) in diabetes care
Davidson, P., Ross, T., & Castor, C. (2018) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2018.03.007 · Cited by 33
Continuous glucose monitors and virtual care in high-risk, racial and ethnic minority populations: Toward promoting health equity
Vrany, E. A., Hill‐Briggs, F., Ephraim, P. L., Myers, A. K., Garnica, P., & Fitzpatrick, S. L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1083145 · Cited by 36
Acceptability of Continuous Glucose Monitoring in Elderly Diabetes Patients Using Multiple Daily Insulin Injections
Volčanšek, Š., Lunder, M., & Janež, A. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0131 · Cited by 32
Self‐reported insulin pump prescribing practices in pediatric type 1 diabetes
Fredette, M. E., Zonfrillo, M. R., Park, S., Quintos, J. B., Gruppuso, P. A., & Topor, L. S. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13213 · Cited by 32
Professional Competencies for Diabetes Technology Use in the Care Setting
Patil, S. P., Albanese-O’Neill, A., Yehl, K., Seley, J. J., & Hughes, A. S. (2022) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106221120889 · Cited by 32
Healthcare resource utilization and cost among patients with type 1 diabetes in the United States
Simeone, J. C., Shah, S., Ganz, M. L., Sullivan, S., Koralova, A., LeGrand, J., & Bushman, J. (2020) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2020.26.11.1399 · Cited by 41
Personal Versus Professional Continuous Glucose Monitoring: When to Use Which on Whom
Longo, R. R., & Sperling, S. B. (2019) · Diabetes Spectrum · doi:10.2337/ds18-0093 · Cited by 30
Open source automated insulin delivery: addressing the challenge
Oliver, N. S., Reddy, M., Marriott, C., Walker, T. C., & Heinemann, L. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0202-1 · Cited by 29
The road from intermittently scanned continuous glucose monitoring to hybrid closed-loop systems. Part B: results from randomized controlled trials
Ridder, F. D., den Brinker, M., & Block, C. E. M. D. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819871903 · Cited by 29
Advanced Technology in the Management of Diabetes: Which Comes First—Continuous Glucose Monitor or Insulin Pump?
Martin, C., Criego, A. B., Carlson, A. L., & Bergenstal, R. M. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1177-7 · Cited by 30
The clinical utility of professional continuous glucose monitoring by pharmacists for patients with type 2 diabetes
Ulrich, H., & Bowen, M. M. (2021) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2021.05.013 · Cited by 28
Health Care Costs, Hospital Admissions, and Glycemic Control Using a Standalone, Real-Time, Continuous Glucose Monitoring System in Commercially Insured Patients With Type 1 Diabetes
Gill, M., Zhu, C., Shah, M., & Chhabra, H. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818777265 · Cited by 23
Chinese clinical guidelines for continuous glucose monitoring (2018 edition)
Bao, Y., Chen, L., Chen, L., Dou, J., Gao, Z., Gao, L., Guo, L., Guo, X., Ji, L., Ji, Q., et al. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3152 · Cited by 23
Use of Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes
Chan, C. L. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0905-0 · Cited by 22
Treatments for diabetes mellitus type II: New perspectives regarding the possible role of calcium and cAMP interaction
Carvalho, D. S., de Almeida, A. A., Borges, A. F., & Campos, D. V. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.04.002 · Cited by 23
The road from intermittently scanned glucose monitoring to hybrid closed-loop systems: Part A. Keys to success: subject profiles, choice of systems, education
Ridder, F. D., den Brinker, M., & Block, C. E. M. D. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819865399 · Cited by 22
The Evolution of Diabetes Technology – Options Toward Personalized Care
Zahid, M., Dowlatshahi, S., Kansara, A., & Sadhu, A. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.04.007 · Cited by 22
Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden
JENDLE, J. H., Smith‐Palmer, J., Delbaere, A., de Portu, S., Papo, N. L., Valentine, W. J., & Roze, S. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0294-z · Cited by 21
Integrating Continuous Glucose Monitoring Into Clinical Practices and Patients' Lives
Hirsch, I. B., & Miller, E. M. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0233 · Cited by 20
Self-citation
Improvements in glycemic outcomes in 4738 children, adolescents, and adults with type 1 diabetes initiating a tubeless insulin management system
Aleppo, G., DeSalvo, D. J., Lauand, F., Huyett, L. M., Chang, A., Vienneau, T., & Ly, T. T. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01366-9 · Cited by 19
Diabetes mellitus type 1 in adults
Dedov, I. I., Shestakova, M. V., Mayorov, A. Y., Шамхалова, М. Ш., Nikonova, T. V., Sukhareva, O. Y., Пекарева, Е. В., Ibragimova, L. I., Mikhina, M. S., Galstyan, G. R., et al. (2020) · Diabetes Mellitus · doi:10.14341/dm12505 · Cited by 19
Summary of clinical investigation plan for The DIATEC trial: in-hospital diabetes management by a diabetes team and continuous glucose monitoring or point of care glucose testing – a randomised controlled trial
Olsen, M. T., Klarskov, C. K., Pedersen‐Bjergaard, U., Hansen, K. B., & Kristensen, P. L. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01595-4 · Cited by 19
Core GRADE 5: rating certainty of evidence—assessing indirectness
Guyatt, G. H., Iorio, A., de Beer, H., Owen, A., Agoritsas, T., Murad, M. H., Karthikeyan, G., Cuello‐García, C. A., Prasad, M., Kim, K. S., et al. (2025) · BMJ · doi:10.1136/bmj-2024-083865 · Cited by 27
Self-citation
Advances in Glucose Monitoring and Automated Insulin Delivery: Supplement to Endocrine Society Clinical Practice Guidelines
Peters, A. L., Ahmann, A., Hirsch, I. B., & Raymond, J. K. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00262 · Cited by 20
Self-citation
Integration of Continuous Glucose Monitoring Data into an Electronic Health Record System: Single-Center Implementation
Aleppo, G., Chmiel, R., Zurn, A., Bandoske, R., Creamer, P., Neubauer, N., Wong, J., Andrade, S. B., & Hauptman, A. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231196168 · Cited by 19
Impact of Medicare Continuous Subcutaneous Insulin Infusion Policies in Patients With Type 1 Diabetes
Argento, N. B., Liu, J., Hughes, A. S., & McAuliffe‐Fogarty, A. H. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819838292 · Cited by 20
When Sugar Reaches the Liver: Phenotypes of Patients with Diabetes and NAFLD
Rojano‐Toimil, A., Rivera‐Esteban, J., Manzano-Núñez, R., Bañares, J., Selva, D. M., Gabriel-Medina, P., Ferrer, R., Pericàs, J. M., & Ciudin, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123286 · Cited by 20
Implementation Strategies for Inpatient Continuous Glucose Monitoring-based Diabetes Management: A Systematic Review
Olsen, M. T., Liarakos, A. L., Wilmot, E. G., Dhatariya, K., Thabit, H., Sánchez-García, D., Nørgaard, K., Pedersen‐Bjergaard, U., Hansen, K. B., Vangoitsenhoven, R., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf074 · Cited by 17
Kernel machine learning methods to handle missing responses with complex predictors. Application in modelling five-year glucose changes using distributional representations
Matabuena, M., Félix, P., Meijide-Garcia, C., & Gudé, F. (2022) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2022.106905 · Cited by 17
Keeping Up with the Diabetes Technology: 2016 Endocrine Society Guidelines of Insulin Pump Therapy and Continuous Glucose Monitor Management of Diabetes
Galderisi, A., Tremblay, E. S., & Cengiz, E. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0944-6 · Cited by 18
Financial Conflicts of Interest Among Authors of Endocrine Society Clinical Practice Guidelines*
Irwig, M. S., Kyinn, M., & Shefa, M. C. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00526 · Cited by 17
Insulin Pump Combined with Flash Glucose Monitoring: A Therapeutic Option to Improve Glycemic Control in Severely Nonadherent Patients with Type 1 Diabetes
Halbron, M., Bourron, O., Andréelli, F., Ciangura, C., Jacqueminet, S., Popelier, M., Bosquet, F., Rouanet, S., Amouyal, C., & Hartemann, A. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0041 · Cited by 17

Authors: Peters, A. L., Ahmann, A. J., Battelino, T., Evert, A., Hirsch, I. B., Murad, M. H., Winter, W. E., & Wolpert, H.
Affiliations: University of Southern California (US)
ORCID: Peters, Anne L.
Ahmann, Andrew J.
Battelino, Tadej
Evert, Alison
Hirsch, Irl B.
Murad, M. Hassan
Winter, William E.
Wolpert, Howard
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 2016-11
Volume: 101
Issue: 11
Pages: 3922-3937
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jc.2016-2534
OpenAlex: W2518284272
Cited by: 250
References: 115
Citations by year: 2026: 13 · 2025: 24 · 2024: 17 · 2023: 19 · 2022: 23 · 2021: 39 · 2020: 31 · 2019: 32 · 2018: 31 · 2017: 19 · 2016: 2
FWCI: 28.12
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords: diabetes technology, insulin pump therapy, continuous glucose monitoring, adults with diabetes, diabetes management, clinical guidelines
MeSH terms: Adult, Blood Glucose, Combined Modality Therapy, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diet, Diabetic, Endocrinology, Humans, Hyperglycemia, Hypoglycemia, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, International Agencies, Patient Education as Topic, Societies, Scientific, Exercise, Drug Monitoring, Monitoring, Ambulatory, Evidence-Based Medicine, Consensus, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Diabetes technology-continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an Endocrine Society clinical practice guideline

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks